中文
| In 2020, sponsors can look forward to new innovations into the clinical trial space, including more virtual or hybrid trials, adaptive trials and other designs that better meet patient needs. In fact, companies are recognizing the value of patient insights (and other stakeholders) for successful trial execution. |
 |
 |
Trials are also becoming more complex than ever before. The amount of data that’s available to sponsors comes as a blessing in disguise — more insights can lead to more effective treatment, yet the disparate sources of data present a significant challenge for accurate and timely analysis. Sophisticated digitization tools promise to streamline clinical data management, reduce costs and accelerate study completion times. |
| At the Drug Information Association (DIA) Global Annual Meeting 2019, Xtalks spoke to industry professionals to gain more insights into the future of clinical trials. |
 |
